Aktis Oncology, Inc. 10-Q filing
Filed 2026-05-11 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-216749
- Form type
- 10-Q
- CIK
- 0002035832
- Primary document
- https://www.sec.gov/Archives/edgar/data/2035832/000119312526216749/ck0002035832-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aktis Oncology, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $3.2M | - | - |
| Operating Income | $-22.7M | - | - |
| Net Income | $-18.3M | - | - |
| Eps Basic | -0.38 | - | - |
| Eps Diluted | -0.38 | - | - |
| Cash And Equivalents | $371.6M | - | - |
| Total Assets | $576.8M | - | - |
| Total Liabilities | $70.7M | - | - |
| Shareholders Equity | $506.1M | - | - |
| Operating Cash Flow | $-24.2M | - | - |
| Capital Expenditures | $1.9M | - | - |